IKT
Inhibikase Therapeutics Inc
2.00$
+3.6%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 49.2% | 69.5% | 44.0% | 92.5% | 100.0% | 100.0% | 97.7% | 98.0% | 99.8% | 99.4% | |
| 7.4% | 5.8% | 13.3% | 48.2% | 94.4% | 96.0% | 28.8% | 63.2% | 57.3% | 76.8% | |
| 7.4% | 5.8% | 13.3% | 48.2% | 94.4% | 96.0% | 92.4% | 91.4% | 98.9% | 98.7% | |
| 41.0% | 63.4% | 16.6% | – | 0.0% | 0.3% | 0.2% | 0.3% | – | – | |
| 0.0% | – | – | – | – | 0.3% | 4.5% | 7.7% | – | – | |
| 929.6% | 605.3% | 127.3% | 11,837.4% | 33.8% | 9.5% | 15.6% | 24.3% | 3.8% | 4.6% | |
| 929.6% | 605.3% | 127.3% | 11,117.5% | 31.9% | 9.5% | 14.8% | 23.7% | 3.8% | 4.6% | |
| 201.9% | 161.3% | 8.2% | 257.3% | 0.3% | 0.6% | 0.6% | 3.7% | 0.1% | – | |
| 265.0% | 124.0% | 33.5% | 2,618.5% | 11.6% | 2.6% | 4.6% | 4.5% | 1.0% | 0.6% | |
| – | – | – | 719.9% | 1.9% | – | – | – | – | – | |
| -829.6% | -505.3% | -27.3% | -11,737.4% | 66.2% | 90.5% | 84.4% | 75.7% | 96.2% | 95.4% | |
| -2,376.7% | -1,510.8% | -227.0% | -31,849.6% | -101.7% | -70.2% | -192.0% | -461.2% | -95.8% | -78.7% | |
| 797.6% | 603.2% | 46.9% | 4,496.6% | 11.3% | 7.1% | 16.9% | 36.8% | 24.0% | 54.3% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.